Literature DB >> 24118933

Spider toxins comprising disulfide-rich and linear amphipathic domains: a new class of molecules identified in the lynx spider Oxyopes takobius.

Alexander A Vassilevski1, Maria Y Sachkova, Anastasija A Ignatova, Sergey A Kozlov, Alexei V Feofanov, Eugene V Grishin.   

Abstract

In addition to the conventional neurotoxins and cytotoxins, venom of the lynx spider Oxyopes takobius was found to contain two-domain modular toxins named spiderines: OtTx1a, 1b, 2a and 2b. These toxins show both insecticidal activity (a median lethal dose against flesh fly larvae of 75 μg·g(-1)) and potent antimicrobial effects (minimal inhibitory concentrations in the range 0.1-10 μm). Full sequences of the purified spiderines were established by a combination of Edman degradation, mass spectrometry and cDNA cloning. They are relatively large molecules (~ 110 residues, 12.0-12.5 kDa) and consist of two distinct modules separated by a short linker. The N-terminal part (~ 40 residues) contains no cysteine residues, is highly cationic, forms amphipathic α-helical structures in a membrane-mimicking environment, and shows potent cytolytic effects on cells of various origins. The C-terminal part (~ 60 residues) is disulfide-rich (five S-S bonds), and contains the inhibitor cystine knot (ICK/knottin) signature. The N-terminal part of spiderines is very similar to linear cytotoxic peptides found in various organisms, whereas the C-terminal part corresponds to the usual spider neurotoxins. We synthesized the modules of OtTx1a and compared their activity to that of full-length mature toxin produced recombinantly, highlighting the importance of the N-terminal part, which retained full-length toxin activity in both insecticidal and antimicrobial assays. The unique structure of spiderines completes the range of two-domain spider toxins.
© 2013 FEBS.

Entities:  

Keywords:  antimicrobial peptide; cytotoxin; inhibitor cystine knot; neurotoxin; spider venom

Mesh:

Substances:

Year:  2013        PMID: 24118933     DOI: 10.1111/febs.12547

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  7 in total

Review 1.  Latarcins: versatile spider venom peptides.

Authors:  Peter V Dubovskii; Alexander A Vassilevski; Sergey A Kozlov; Alexey V Feofanov; Eugene V Grishin; Roman G Efremov
Journal:  Cell Mol Life Sci       Date:  2015-08-19       Impact factor: 9.261

2.  Insights into Antimicrobial Peptides from Spiders and Scorpions.

Authors:  Xiuqing Wang; Guangshun Wang
Journal:  Protein Pept Lett       Date:  2016       Impact factor: 1.890

3.  Modular toxin from the lynx spider Oxyopes takobius: Structure of spiderine domains in solution and membrane-mimicking environment.

Authors:  Kirill D Nadezhdin; Daria D Romanovskaia; Maria Y Sachkova; Peter B Oparin; Sergey I Kovalchuk; Eugene V Grishin; Alexander S Arseniev; Alexander A Vassilevski
Journal:  Protein Sci       Date:  2017-02-12       Impact factor: 6.725

Review 4.  Convergent evolution of defensin sequence, structure and function.

Authors:  Thomas M A Shafee; Fung T Lay; Thanh Kha Phan; Marilyn A Anderson; Mark D Hulett
Journal:  Cell Mol Life Sci       Date:  2016-08-24       Impact factor: 9.261

5.  Linear Peptides-A Combinatorial Innovation in the Venom of Some Modern Spiders.

Authors:  Lucia Kuhn-Nentwig; Heidi E L Lischer; Stano Pekár; Nicolas Langenegger; Maria J Albo; Marco Isaia; Wolfgang Nentwig
Journal:  Front Mol Biosci       Date:  2021-07-06

6.  Neurotoxin Merging: A Strategy Deployed by the Venom of the Spider Cupiennius salei to Potentiate Toxicity on Insects.

Authors:  Benjamin Clémençon; Lucia Kuhn-Nentwig; Nicolas Langenegger; Lukas Kopp; Steve Peigneur; Jan Tytgat; Wolfgang Nentwig; Benjamin P Lüscher
Journal:  Toxins (Basel)       Date:  2020-04-12       Impact factor: 4.546

Review 7.  Spider Venom: Components, Modes of Action, and Novel Strategies in Transcriptomic and Proteomic Analyses.

Authors:  Nicolas Langenegger; Wolfgang Nentwig; Lucia Kuhn-Nentwig
Journal:  Toxins (Basel)       Date:  2019-10-22       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.